DEREK T. BRASLOW

Email Derek T. Braslow | Download V Card

Education:

• 1993 - Bachelor of Arts, University of Pennsylvania
• 1996 - Juris Doctorate, Temple University School of Law

Admissions:

• Supreme Court of New Jersey (1996)
• Supreme Court of Pennsylvania (1997)
• Superior Court of the District of Columbia (1998)
• United States District Court, Eastern District of Pennsylvania (2001)
• United States District Court, District of New Jersey (1996)
• United States District Court, District of Columbia (2002)
• United States District Court, Western District of Michigan (2003)
• United States District Court, Eastern and Western Districts of Arkansas (2006)
• United States District Court, Eastern District of Missouri (2006)
• United States Court of Appeals, Third Circuit (2000)

Memberships:

• Temple Law Alumni Association
• Philadelphia Trial Lawyers Association
• Pennsylvania Association for Justice
• American Association for Justice
• Brandeis Law Society
• Golden Slipper Club & Charities
• Board Member, Suburban Jewish Community Center-Bnai Aaron
• Philadelphia Bar Association

Awards, Accomplishments, & Recognitions:

• Regional Champion, Association of Trial Lawyers of America (ATLA) Mock Trial Competition
• Philadelphia Trial Lawyers Association, James J. Mandarino Award for Trial Advocacy

Derek T. Braslow is a founding partner of Pogust Braslow & Millrood LLC and has devoted his legal career to fighting on behalf of his injured clients against drug companies, health institutions, and insurance companies. Derek has been an advocate for children, adolescents and adults who have become suicidal allegedly as a result of ingesting psychotropic medication. He has been a featured speaker on clinical trials, bioethics and pharmaceutical litigation and policy at conferences sponsored by the American Bar Association and the International Center for the Study of Psychiatry and Psychology. Additionally, he has testified before the FDA's Psychopharmacologic Drug Advisory Committee regarding the risk of suicide and antidepressants and has been counsel to numerous clients who have testified before the FDA's Subcommittees regarding the deadly risks of ADHD drugs and antidepressants for children and adolescents.